MDH2 and cancer: Altered metabolism caused by mutations in MDH2 has been implicated in various cancers, including an association with metastasis in pheochromocytomas and paragangliomas [34], and a germline splice site mutation leading to reduced MDH2 activity has been identified in a familial case of paraganglioma [35].